FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 32, Pages 19415-19424
Publisher
Proceedings of the National Academy of Sciences
Online
2020-07-28
DOI
10.1073/pnas.2009237117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
- (2019) Kristen E. Mengwasser et al. MOLECULAR CELL
- Genetic interaction networks in cancer cells
- (2019) Barbara Mair et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- A decade of clinical development of PARP inhibitors in perspective
- (2019) J Mateo et al. ANNALS OF ONCOLOGY
- Amplification of the mutation-carrying BRCA2 allele promotes RAD51 loading and PARP inhibitor resistance in the absence of reversion mutations.
- (2019) Pyoung Hwa Park et al. MOLECULAR CANCER THERAPEUTICS
- Essential Saccharomyces cerevisiae genome instability suppressing genes identify potential human tumor suppressors
- (2019) Anjana Srivatsan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2018) Ewa Gogola et al. CANCER CELL
- DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity
- (2018) Rajat Gupta et al. CELL
- Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls
- (2018) John Paul Shen et al. JOURNAL OF MOLECULAR BIOLOGY
- Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
- (2018) Stephen J. Pettitt et al. Nature Communications
- A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
- (2018) James X. Sun et al. PLoS Computational Biology
- Mechanisms of PARP inhibitor sensitivity and resistance
- (2018) Alan D. D’Andrea DNA REPAIR
- CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
- (2018) Michal Zimmermann et al. NATURE
- The BioGRID interaction database: 2019 update
- (2018) Rose Oughtred et al. NUCLEIC ACIDS RESEARCH
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- Pathways and Mechanisms that Prevent Genome Instability in Saccharomyces cerevisiae
- (2017) Christopher D. Putnam et al. GENETICS
- Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition
- (2017) Stephanie Lheureux et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer
- (2017) Saima Hassan et al. MOLECULAR CANCER THERAPEUTICS
- Synthetic lethality and cancer
- (2017) Nigel J. O'Neil et al. NATURE REVIEWS GENETICS
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Pathways and Mechanisms that Prevent Genome Instability in Saccharomyces cerevisiae
- (2017) Christopher D. Putnam et al. GENETICS
- Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes
- (2017) Thomas A. Ward et al. PLoS One
- Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site
- (2016) Jack C Exell et al. Nature Chemical Biology
- A genetic network that suppresses genome rearrangements in Saccharomyces cerevisiae and contains defects in cancers
- (2016) Christopher D. Putnam et al. Nature Communications
- DNA damage foci: Meaning and significance
- (2015) Kai Rothkamm et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line
- (2014) Bianca Schröder-Heurich et al. BMC CANCER
- Rad52/Rad59-dependent Recombination as a Means to Rectify Faulty Okazaki Fragment Processing
- (2014) Miju Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Flap Endonuclease 1
- (2013) Lata Balakrishnan et al. Annual Review of Biochemistry
- Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer
- (2013) M. Ihnen et al. MOLECULAR CANCER THERAPEUTICS
- Synthetic Lethality between Gene Defects Affecting a Single Non-essential Molecular Pathway with Reversible Steps
- (2013) Andrei Zinovyev et al. PLoS Computational Biology
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Bioinformatic identification of genes suppressing genome instability
- (2012) C. D. Putnam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The quantitative proteome of a human cell line
- (2011) M. Beck et al. Molecular Systems Biology
- Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
- (2010) Yvette Drew et al. JNCI-Journal of the National Cancer Institute
- FEN1 Functions in Long Patch Base Excision Repair Under Conditions of Oxidative Stress in Vertebrate Cells
- (2010) K. Asagoshi et al. MOLECULAR CANCER RESEARCH
- Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma
- (2009) W. Sakai et al. CANCER RESEARCH
- Targeted therapy for cancer using PARP inhibitors
- (2008) Christopher J Lord et al. CURRENT OPINION IN PHARMACOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started